ASTRO 2026

ASTRO: fractionated radiosurgery lessens brain metastases recurrence
By Amerigo Allegretto
Focused radiation therapy over three to five sessions after surgery for a large brain metastasis reduced recurrence risk.
September 28, 2026
Astro 2026 Thumb 2
ASTRO: Navigator program improves access for African American breast cancer patients
By Will Morton
Afua Ofori-Darko, a medical student at Case Western Reserve, presented early phase I results of a structured patient navigation program.
September 28, 2026
Img 2190
Accuray, Samsung NeuroLogica collaborate on CyberKnife platform
By AuntMinnie.com staff writers
The companies will pursue advanced volumetric imaging capabilities for the CyberKnife System.
September 28, 2026
Accuray Cyber Knife S7 System
ITM shares new data on Lu-177-edotreotide at ASTRO 2026
By AuntMinnie.com staff writers
The poster presentations included real-world and dosimetry data for ITM-11.
September 27, 2026
Isotopes1
ASTRO: Elekta expands adaptive radiotherapy portfolio
By AuntMinnie.com staff writers
Elekta Prostate Guideway is a single-room workflow for high-dose-rate prostate brachytherapy that combines imaging, planning, and treatment adaptation.
September 27, 2026
Elekta
ASTRO: Low-dose RT tied to fewer knee replacements
By Amerigo Allegretto
Patients who underwent low-dose RT had longer symptom relief, less joint deterioration, and lower disability risk.
September 27, 2026
Knee Joint Pain 400
ASTRO: Ultra-low-dose RT controls myeloma bone pain
By Will Morton
The pain response rate was 59% at four weeks.
September 27, 2026
Astro1
ASTRO: Limb-sparing care now standard for extremity sarcoma
By Will Morton
In the 1970s, over 50% of extremity soft tissue sarcomas were treated by amputation.
September 27, 2026
Thomas DeLaney, MD, delivered a talk at ASTRO September 27 on preserving limbs in patients with extremity sarcoma.
ASTRO: Siemens unveils Accela radiotherapy system
By AuntMinnie.com staff writers
NeoArc allows stereotactic treatment to be delivered within a single breath hold.
September 27, 2026
Siemens Healthineers' Accela radiotherapy system
ASTRO: Proton RT controls high-risk neuroblastoma
By Will Morton
Findings support PRT as a strategy to reduce long-term morbidity without compromising oncologic outcomes.
September 26, 2026
Astro 2026 Thumb 2
ASTRO: How does tumor location affect survival in patients with esophageal cancer?
By Will Morton
Upper esophageal tumors were associated with the best survival, while middle esophageal location carried significantly worse odds.
September 26, 2026
Astro 2026 Thumb
Fuse Oncology expands FuseRx workflow to full radiation oncology team
By AuntMinnie.com staff writers
The platform streamlines workflows from consult note and treatment intent through simulation, treatment planning, and scheduling.
September 25, 2026
Fuse Oncology Fuse Rx Clinical Workflow Platform
Page 1 of 2
Next Page